reliable enough to make necessary adjustments. The
results expected from this project are going to guide
the providers of healthcare into earlier identification
and intervention for chronic diseases with the aim of
rising patient outcomes and lowering health care costs
in facilities. This paper focuses on the integration of
predictive analytics in Medicare patient care. Thus, it
helps in giving personalized and proactive healthcare
solutions, transforming the management of chronic
diseases.
State-of-the-art machine learning-based disease
prediction systems face substantial challenges like
dependency on the quality of the dataset, challenges
in feature selection, and origination of bias through
the use of a single algorithm. These issues might lead
to false predictions and the defeat of precocity of
diseases. To counter these issues, this project aims at
designing a multi-algorithm machine learning system
that utilizes a variety of supervised learning models
in order to have an increased level of accuracy
pertaining to predictiveness and to take away the bias.
Data preprocessing along with advanced techniques
of feature selection is also crucial in order to improve
quality to a large extent. These need to be expanded
to include different demographics to make the models
more generalizable and less likely to overfit.
Evaluation of the learning models after training will
also increase the reliability of predictions. Lastly, it
will evaluate and compare the performance of
different machine learning models applied in
handling various diseases, including heart disease,
diabetes, and Parkinson's disease. By addressing
these objectives, the project aims to offer a strong
framework for more accurate and reliable disease
prediction.
2 LITERATURE SURVEY
The inclusion of machine learning (ML) in healthcare
for disease prediction has highlighted significant
challenges and limitations in current systems. A
major issue is the dependency on data quality. Poor
data, characterized by missing entries,
inconsistencies, and class imbalances, often results in
unreliable predictions. Kourentzes et al. and Lipton et
al. demonstrated how inadequate data quality
adversely impacts model accuracy, especially in
predicting cardiovascular disease mortality risks.
Beam and Kohane also emphasize that data
preprocessing is critical for healthcare applications to
address these issues effectively.
Another key challenge is effective feature
selection. Guyon and Elisseeff identified that
inefficient methods tend to overfit, capturing noise
rather than meaningful patterns. Prominent
techniques like Recursive Feature Elimination and
LASSO (Zou and Hastie) have proven useful but
often lack consistency across varied datasets. Miotto
et al. highlighted the need for dimensionality
reduction techniques to avoid overfitting while
preserving model effectiveness.
Algorithmic bias is another significant concern.
Obermeyer et al. observed that models trained on
homogeneous datasets struggle to generalize, thereby
exacerbating health disparities among demographic
groups. To address this, multi-algorithm systems
leveraging strengths from multiple supervised
learning models have emerged as a promising
solution. For instance, Hodge and Austin
demonstrated how ensemble methods could enhance
accuracy and reduce bias, particularly in predicting
diabetes and heart disease (Chakraborty et al.,).
Esteva et al. explored how deep learning models
could reduce bias by integrating diverse datasets.
Advanced preprocessing and feature engineering
techniques also play a critical role in improving
model performance. Sun et al. conducted systematic
reviews highlighting the importance of preprocessing
in enhancing generalization and minimizing
overfitting. Topol emphasized the importance of
high-quality preprocessing for AI-driven healthcare
solutions. Furthermore, Wang and Preininger stressed
the need for diverse datasets to ensure robust and
unbiased model training.
Model evaluation is equally crucial. Good post-
training evaluation techniques, such as cross-
validation, ensure performance optimization and
reliability (Varma & Simon). Liu et al. demonstrated
that systematic evaluations could match or
outperform human-level diagnostic accuracy in
certain medical domains.
Recent advances in machine learning have shown
immense potential for addressing these challenges.
Liang et al. applied AI to pediatric disease
diagnostics, achieving high accuracy and
interpretability. Shickel et al. highlighted the growing
role of deep learning in analyzing electronic health
records (EHRs), enabling better predictions for
chronic diseases. Rajkomar et al. explored how ML
could revolutionize patient care by integrating
precision medicine and scalable analytics.
Additionally, Esteva et al. and Litjens et al.
demonstrated how deep learning models, such as
convolutional neural networks, could achieve
dermatologist-level performance in detecting skin
conditions and medical imaging, respectively.
Advances in these areas pave the way for